1994
DOI: 10.1016/0005-2760(94)90034-5
|View full text |Cite
|
Sign up to set email alerts
|

Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
98
1

Year Published

2000
2000
2022
2022

Publication Types

Select...
8
2

Relationship

1
9

Authors

Journals

citations
Cited by 177 publications
(104 citation statements)
references
References 38 publications
2
98
1
Order By: Relevance
“…GD3 is known to be located in human peripheral nerve and rat Schwann cell surface (Levison and McCarthy, 1989;Svennerholm et al, 1994). Goodyear et al (1999) showed that anti-GD3 mAbs were elicited from mice sensitized with LPS of C. jejuni from patients with Miller Fisher syndrome and that they possess a binding activity to the NMJ region of mice.…”
Section: Discussionmentioning
confidence: 99%
“…GD3 is known to be located in human peripheral nerve and rat Schwann cell surface (Levison and McCarthy, 1989;Svennerholm et al, 1994). Goodyear et al (1999) showed that anti-GD3 mAbs were elicited from mice sensitized with LPS of C. jejuni from patients with Miller Fisher syndrome and that they possess a binding activity to the NMJ region of mice.…”
Section: Discussionmentioning
confidence: 99%
“…Its function is not completely understood, but it is thought to play an important role in the attachment of tumor cells to extracellular matrix proteins [43]. GD2 expression in normal fetal and adult tissues is primarily restricted to the neurons, skin melanocytes and peripheral nerve fibers [44]. Due to its high and relatively tumor-specific expression, GD2 is an attractive target for tumor-specific antibody therapy.…”
Section: Gd2 and Anti-gd2 Antibody Immunotherapymentioning
confidence: 99%
“…22,23 Polysialylated complex gangliosides are more concentrated in the Recent studies have indicated that a proportion of patients with FS and AMAN form of GBS who were seronegative when tested against individual gangliosides in solid phase assays become seropositive when tested with mixture of two different gangliosides. These novel observations raise the possibility that number of seronegative patients in GBS, particularly AIDP variant, could decrease as sera from these patients are tested against mixture of gangliosides/glycolipids.…”
Section: Gangliosidesmentioning
confidence: 99%